Evidence map›Paper›PMID 31984424›Full record

ArticleHuman molecular genetics2020

DNMT1 mutations leading to neurodegeneration paradoxically reflect on mitochondrial metabolism.

Alessandra Maresca, Valentina Del Dotto, Mariantonietta Capristo, Emanuela Scimonelli, Francesca Tagliavini, Luca Morandi, Concetta Valentina Tropeano, Leonardo Caporali, Susan Mohamed, Marina Roberti and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. TDP-43 controls RNA structure through high affinity lattice interactions.bioRxiv : the preprint server for biology · 2025
    Article
  6. Mitochondrial DNA signals driving immune responses: Why, How, Where?Cell communication and signaling : CCS · 2025
    Review
  7. Article
  8. Article
  9. Cytosine methylase and hydroxymethylase activity in mammalian mitochondria.Frontiers in cell and developmental biology · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 4 institutions in 2 countries.

Alessandra MarescaIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna 40139, Italy.
Valentina Del DottoDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna 40139, Italy.
Mariantonietta CapristoIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna 40139, Italy.
Emanuela ScimonelliDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna 40139, Italy.
Francesca TagliaviniIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna 40139, Italy.
Luca MorandiDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna 40139, Italy.
Concetta Valentina TropeanoIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna 40139, Italy.
Leonardo CaporaliIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna 40139, Italy.
Susan MohamedIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna 40139, Italy.
Marina RobertiDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Bari 70126, Italy.
Letizia ScandiffioDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Bari 70126, Italy.
Mirko ZaffagniniDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna 40126, Italy.
Jacopo RossiDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna 40126, Italy.
Martina CappellettiDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna 40126, Italy.
Francesco MusianiDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna 40126, Italy.
Manuela ContinIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna 40139, Italy.
Roberto RivaIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna 40139, Italy.
Rocco LiguoriIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna 40139, Italy.
Fabio PizzaIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna 40139, Italy.
Chiara La MorgiaIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna 40139, Italy.
Elena AntelmiDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna 40139, Italy.
Paola Loguercio PolosaDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Bari 70126, Italy.
Emmanuel MignotDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94304, USA.
Claudia ZannaDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna 40126, Italy.
Giuseppe PlazziIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna 40139, Italy.
Valerio CarelliIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna 40139, Italy.
University of Bologna · ITIstituto delle Scienze Neurologiche di Bologna · ITUniversity of Bari Aldo Moro · ITStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ADCA-DN and HSN-IE are rare neurodegenerative syndromes caused by dominant mutations in the replication foci targeting sequence (RFTS) of the DNA methyltransferase 1 (DNMT1) gene. Both phenotypes resemble mitochondrial disorders, and mitochondrial dysfunction was first observed in ADCA-DN. To explore mitochondrial involvement, we studied the effects of DNMT1 mutations in fibroblasts from four ADCA-DN and two HSN-IE patients. We documented impaired activity of purified DNMT1 mutant proteins, which in fibroblasts results in increased DNMT1 amount. We demonstrated that DNMT1 is not localized within mitochondria, but it is associated with the mitochondrial outer membrane. Concordantly, mitochondrial DNA failed to show meaningful CpG methylation. Strikingly, we found activated mitobiogenesis and OXPHOS with significant increase of H2O2, sharply contrasting with a reduced ATP content. Metabolomics profiling of mutant cells highlighted purine, arginine/urea cycle and glutamate metabolisms as the most consistently altered pathways, similar to primary mitochondrial diseases. The most severe mutations showed activation of energy shortage AMPK-dependent sensing, leading to mTORC1 inhibition. We propose that DNMT1 RFTS mutations deregulate metabolism lowering ATP levels, as a result of increased purine catabolism and urea cycle pathways. This is associated with a paradoxical mitochondrial hyper-function and increased oxidative stress, possibly resulting in neurodegeneration in non-dividing cells.

Indexed as

Genetic Predisposition to DiseaseDeafnessDNA (Cytosine-5-)-Methyltransferase 1DNA MethylationFemaleFibroblastsHereditary Sensory and Autonomic NeuropathiesHumansMaleMitochondriaMutationNarcolepsyNerve DegenerationOxidative PhosphorylationPhenotypeProtein Processing, Post-TranslationalDNA (Cytosine-5-)-Methyltransferase 1DNMT1 protein, human

Identifiers

PMID31984424
PMCPMC7372549
OpenAlexW3003545207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.